Seaport Therapeutics, Inc. · NASDAQ:SPTX

Seaport Therapeutics, Inc. shareholders

As of Sep 30, 2026, 71 institutions reported holding Seaport Therapeutics, Inc., 71.3% of its shares. Largest: ARCH Venture Management, LLC, General Atlantic, L.P. and Sofinnova Investments, Inc. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Seaport Therapeutics, Inc.ChangeFiled
ARCH Venture Management, LLC6.29M11.8%no changeNov 16, 2026
General Atlantic, L.P.6.1M11.4%no changeNov 13, 2026
Sofinnova Investments, Inc.3.56M6.7%no changeNov 16, 2026
Goldman Sachs2.18M4.1%+3,201Nov 16, 2026
Trv Gp VI, LLC2.06M3.9%no changeNov 16, 2026
CPP Investments1.98M3.7%no changeNov 16, 2026
Fidelity1.84M3.4%+653KNov 10, 2026
Foresite Capital Management VI LLC1.78M3.3%no changeNov 16, 2026
JPMorgan1.6M3.0%−219KNov 12, 2026
Jennison Associates LLC1.15M2.2%+71,563Nov 13, 2026

Seaport Therapeutics, Inc. insider trades